Cosmos Health posts record preliminary Q2 revenue

Cosmos Health

07/07/2026 14:50

Overview
US healthcare group posts preliminary Q2 revenue of approximately $19.4 mln, up 31.5% year-over-year
Company repurchased 3.64 mln shares for about $700,000 under $5 mln buyback program

Outlook
Company did not provide specific guidance for future quarters or full-year results

Result Drivers
BUSINESS EXECUTION - CEO attributed record revenue to ongoing execution across the company's platform

Company press release: ID:nGNXbyBrYw

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$19.40 mln
 

Analyst Coverage
Wall Street's median 12-month price target for Cosmos Health Inc is $4.50, about 1,567.3% above its July 6 closing price of $0.27

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)